edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Newron Pharmaceuticals has announced that its partner for Japan, EA Pharma (a subsidiary of Eisai), has initiated its Phase III clinical trial for evenamide. This is a key milestone for the clinical development of evenamide in schizophrenia as it represent an important requirement to satisfy regulators in the region. The announcement also reflects sustained progress for the candidate, which has a novel mechanism of action to address treatment-resistant schizophrenia.
TMT | Comment
Industrials | Comment
Industrials | Comment
Get access to the very latest content matched to your personal investment style.